Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia

Trends in Pharmacological Sciences

Volumn 32, Issue 9, 2011, Pages 507-513

  Lodge, Daniel J ^a   Grace, Anthony A ^b  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; BENZODIAZEPINE DERIVATIVE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT;

ADJUVANT THERAPY; ATAXIA; BRAIN BLOOD FLOW; CELL MEMBRANE DEPOLARIZATION; COGNITIVE DEFECT; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; HIPPOCAMPUS; HUMAN; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; VENTRAL TEGMENTUM;

ALLOSTERIC REGULATION; ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE; HIPPOCAMPUS; HUMANS; NEURONS; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; SCHIZOPHRENIA;

EID: 80052035263     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2011.05.001     Document Type: Review

References (64)

1. S.A. Stilo, and R.M. Murray The epidemiology of schizophrenia: replacing dogma with knowledge Dialogues Clin. Neurosci. 12 2010 305 315
2. S.R. Kay The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr. Bull. 13 1987 261 276 (Pubitemid 18039085)
3. R.W. Heinrichs, and K.K. Zakzanis Neurocognitive deficit in schizophrenia: a quantitative review of the evidence Neuropsychology 12 1998 426 445 (Pubitemid 28323862)
4. A. Abi-Dargham Do we still believe in the dopamine hypothesis? New data bring new evidence Int. J. Neuropsychopharmacol. 7 Suppl. 1 2004 S1 S5
5. M. Laruelle, and A. Abi-Dargham Dopamine as the wind of psychotic fire: new evidence from brain imaging studies J. Psychopharmacol. 13 1999 358 371 (Pubitemid 30055180)
6. I. Creese Dopamine receptors and average clinical doses Science 194 1976 546
7. P. Seeman Brain receptors for antipsychotic drugs and dopamine: direct binding assays Proc. Natl. Acad. Sci. U.S.A. 72 1975 4376 4380
8. P. Seeman Psychosis pathways converge via D2 high dopamine receptors Synapse 60 2006 319 346 (Pubitemid 44134353)
9. A. Abi-Dargham Increased baseline occupancy of D2 receptors by dopamine in schizophrenia Proc. Natl. Acad. Sci. U.S.A. 97 2000 8104 8109 (Pubitemid 30460780)
10. M. Laruelle Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects Proc. Natl. Acad. Sci. U.S.A. 93 1996 9235 9240
11. L.S. Kegeles Increased synaptic dopamine function in associative regions of the striatum in schizophrenia Arch. Gen. Psychiatry 67 2010 231 239
12. D.S. Janowsky Provocation of schizophrenic symptoms by intravenous administration of methylphenidate Arch. Gen. Psychiatry 28 1973 185 191
13. J.A. Lieberman Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N. Engl. J. Med. 353 2005 1209 1223 (Pubitemid 41345943)
14. C.A. Tamminga The hippocampal formation in schizophrenia Am. J. Psychiatry 167 2010 1178 1193
15. A.P. Weiss Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia Biol. Psychiatry 53 2003 48 55 (Pubitemid 36050935)
16. S. Heckers Impaired recruitment of the hippocampus during conscious recollection in schizophrenia Nat. Neurosci. 1 1998 318 323
17. P.J. Harrison The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain 122 Pt 4 1999 593 624 (Pubitemid 29158770)
18. S. Heckers, and C. Konradi Hippocampal neurons in schizophrenia J. Neural Transm. 109 2002 891 905 (Pubitemid 34810781)
19. M.D. Nelson Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study Arch. Gen. Psychiatry 55 1998 433 440 (Pubitemid 28237277)
20. S.A. Schobel Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders Arch. Gen. Psychiatry 66 2009 938 946
21. D. Malaspina SPECT study of visual fixation in schizophrenia and comparison subjects Biol. Psychiatry 46 1999 89 93 (Pubitemid 29296821)
22. D.R. Medoff Probing the human hippocampus using rCBF: contrasts in schizophrenia Hippocampus 11 2001 543 550 (Pubitemid 33100375)
23. Lewandowski, N.M. et al. (2005) Isolating hippocampal subregions most vulnerable to schizophrenia, In Annual. Society. Neuroscience Meeting Program Number, Program Number: 443.1
24. V. Molina Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia Psychiatry Res. - Neuroimaging 124 2003 163 175 (Pubitemid 37410344)
25. C.A. Tamminga, and H.H. Holcomb Phenotype of schizophrenia: a review and formulation Mol. Psychiatry 10 2005 27 39 (Pubitemid 40139587)
26. C.D. Blaha Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor-mediated changes in dopamine efflux in the rat nucleus accumbens Eur. J. Neurosci. 9 1997 902 911
27. M. Legault, and R.A. Wise Injections of N-methyl-d-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens Synapse 31 1999 241 249 (Pubitemid 29070284)
28. S.B. Floresco Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons J. Neurosci. 21 2001 4915 4922 (Pubitemid 32565650)
29. S.B. Floresco Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission Nat. Neurosci. 6 2003 968 973 (Pubitemid 37064759)
30. D.J. Lodge, and A.A. Grace The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation Neuropsychopharmacology 31 2006 1356 1361
31. D.J. Lodge, and A.A. Grace Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia J. Neurosci. 27 2007 11424 11430 (Pubitemid 47621327)
32. D.J. Lodge, and A.A. Grace Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization J. Neurosci. 28 2008 7876 7882
33. I.M. White Amphetamine-induced hyperlocomotion in rats: Hippocampal modulation of the nucleus accumbens Hippocampus 16 2006 596 603 (Pubitemid 44405262)
34. A.A. Grace, and B.S. Bunney The control of firing pattern in nigral dopamine neurons: burst firing J. Neurosci. 4 1984 2877 2890 (Pubitemid 15224432)
35. D.J. Lodge, and A.A. Grace Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia Behav. Brain Res. 204 2009 306 312
36. H. Moore A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia Biol. Psychiatry 60 2006 253 264 (Pubitemid 44093447)
37. S. Kapur Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia Am. J. Psychiatry 160 2003 13 23 (Pubitemid 36042420)
38. O. Agid Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected Arch. Gen. Psychiatry 60 2003 1228 1235 (Pubitemid 37494076)
39. S. Kapur Evidence for onset of antipsychotic effects within the first 24 hours of treatment Am. J. Psychiatry 162 2005 939 946 (Pubitemid 40676207)
40. S. Leucht Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended Biol. Psychiatry 57 2005 1543 1549 (Pubitemid 40805384)
41. M. Li Time course of the antipsychotic effect and the underlying behavioral mechanisms Neuropsychopharmacology 32 2007 263 272 (Pubitemid 46106933)
42. B.S. Bunney, and A.A. Grace Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity Life Sci. 23 1978 1715 1727 (Pubitemid 9072475)
43. A.A. Grace The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia J. Neural Transm. 36 1992 91 131
44. M. Melis Haloperidol does not produce dopamine cell depolarization-block in paralyzed, unanesthetized rats Brain Res. 783 1998 127 132 (Pubitemid 28131430)
45. L.A. Chiodo, and B.S. Bunney Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons J. Neurosci. 5 1985 2539 2544 (Pubitemid 15226946)
46. Perez, S.M. and Lodge, D.J. (2010) Increased dopamine receptor sensitivity in an animal model of schizophrenia. Program No. 62.22. 2010 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2010. Online
47. Valenti, O. et al. (2009) Antipsychotic drugs elicit a rapid depolarization inactivation of VTA DA neuron firing in rat model of schizophrenia via the nucleus accumbens-ventral pallidal pathway. Program No. 646.10. 2010 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2010. Online. 646, 10
48. F.M. Benes Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars Proc. Natl. Acad. Sci. U.S.A. 104 2007 10164 10169 (Pubitemid 47175280)
49. D.A. Lewis Cortical inhibitory neurons and schizophrenia Nat. Rev. Neurosci. 6 2005 312 324 (Pubitemid 40469985)
50. D.J. Lodge A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia J. Neurosci. 29 2009 2344 2354
51. O.M. Wolkowitz, and D. Pickar Benzodiazepines in the treatment of schizophrenia: A review and reappraisal Am. J. Psychiatry 148 1991 714 726
52. U. Rudolph GABAA receptor subtypes: Dissecting their pharmacological functions Trends Pharmacol. Sci. 22 2001 188 194 (Pubitemid 32244305)
53. I. Brunig Intact sorting, targeting, and clustering of ?.-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro J. Compar. Neurol. 443 2002 43 55 (Pubitemid 34027568)
54. N. Collinson Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the ?.5 subunit of the GABAA receptor J. Neurosci. 22 2002 5572 5580 (Pubitemid 35386478)
55. G. Buzsaki Functions for interneuronal nets in the hippocampus Can. J. Physiol. Pharmacol. 75 1997 508 515 (Pubitemid 27327053)
56. M.M. Savic Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at [alpha]1 plus [alpha]5 versus [alpha]2 plus [alpha]3 subunits account for dissimilarities in behavioral effects in rats? Prog. Neuro-Psychopharmacol. Biol. Psychiatry 34 2010 376 386
57. Gill, K.M. et al. (2011) A novel α5GABAAR positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia. Neuropsychopharmacology 2011 May 11. [Epub ahead of print]
58. A.A. Grace, and B.S. Bunney Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence Science 210 1980 654 656 (Pubitemid 11220281)
59. A.A. Grace, and B.S. Bunney Intracellular and extracellular electrophysiology of nigral dopaminergic neurons - 1. Identification and characterization Neuroscience 10 1983 301 315 (Pubitemid 13019570)
60. A. Grace, and S. Onn Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro J. Neurosci. 9 1989 3463 3481 (Pubitemid 19260019)
61. A.A. Grace, and B.S. Bunney Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity Brain Res. 333 1985 271 284 (Pubitemid 15093585)
62. A.A. Grace, and B.S. Bunney The control of firing pattern in nigral dopamine neurons: single spike firing J. Neurosci. 4 1984 2866 2876 (Pubitemid 15224431)
63. W. Schultz Predictive reward signal of dopamine neurons J. Neurophysiol. 80 1998 1 27 (Pubitemid 28326237)
64. A.A. Grace Regulation of firing of dopaminergic neurons and control of goal-directed behaviors Trends Neurosci. 30 2007 220 227 (Pubitemid 46654234)